Is Rapamycin a Dietary Restriction Mimetic?
- PMID: 30854544
- PMCID: PMC6909904
- DOI: 10.1093/gerona/glz060
Is Rapamycin a Dietary Restriction Mimetic?
Abstract
Since the initial suggestion that rapamycin, an inhibitor of target of rapamycin (TOR) nutrient signaling, increased lifespan comparable to dietary restriction, investigators have viewed rapamycin as a potential dietary restriction mimetic. Both dietary restriction and rapamycin increase lifespan across a wide range of evolutionarily diverse species (including yeast, Caenorhabditis elegans, Drosophila, and mice) as well as reducing pathology and improving physiological functions that decline with age in mice. The purpose of this article is to review the research comparing the effect of dietary restriction and rapamycin in mice. The current data show that dietary restriction and rapamycin have different effects on many pathways and molecular processes. In addition, these interventions affect the lifespan of many genetically manipulated mouse models differently. In other words, while dietary restriction and rapamycin may have similar effects on some pathways and processes; overall, they affect many pathways/processes quite differently. Therefore, rapamycin is likely not a true dietary restriction mimetic. Rather dietary restriction and rapamycin appear to be increasing lifespan and retarding aging largely through different mechanisms/pathways, suggesting that a combination of dietary restriction and rapamycin will have a greater effect on lifespan than either manipulation alone.
Keywords: Dietary restriction; Insulin sensitivity; Lifespan; Rapamycin; TOR.
© The Author(s) 2019. Published by Oxford University Press on behalf of The Gerontological Society of America.
Figures
Similar articles
-
Short-term treatment with rapamycin and dietary restriction have overlapping and distinctive effects in young mice.J Gerontol A Biol Sci Med Sci. 2013 Feb;68(2):108-16. doi: 10.1093/gerona/gls127. Epub 2012 May 8. J Gerontol A Biol Sci Med Sci. 2013. PMID: 22570137 Free PMC article.
-
Rapamycin-mediated lifespan increase in mice is dose and sex dependent and metabolically distinct from dietary restriction.Aging Cell. 2014 Jun;13(3):468-77. doi: 10.1111/acel.12194. Epub 2014 Feb 9. Aging Cell. 2014. PMID: 24341993 Free PMC article.
-
Characterization of Effects of mTOR Inhibitors on Aging in Caenorhabditis elegans.J Gerontol A Biol Sci Med Sci. 2024 Nov 1;79(11):glae196. doi: 10.1093/gerona/glae196. J Gerontol A Biol Sci Med Sci. 2024. PMID: 39150882 Free PMC article.
-
Dietary restriction and lifespan: Lessons from invertebrate models.Ageing Res Rev. 2017 Oct;39:3-14. doi: 10.1016/j.arr.2016.12.005. Epub 2016 Dec 19. Ageing Res Rev. 2017. PMID: 28007498 Free PMC article. Review.
-
Longevity, aging and rapamycin.Cell Mol Life Sci. 2014 Nov;71(22):4325-46. doi: 10.1007/s00018-014-1677-1. Cell Mol Life Sci. 2014. PMID: 25015322 Free PMC article. Review.
Cited by
-
Rapamycin for longevity: opinion article.Aging (Albany NY). 2019 Oct 4;11(19):8048-8067. doi: 10.18632/aging.102355. Epub 2019 Oct 4. Aging (Albany NY). 2019. PMID: 31586989 Free PMC article.
-
Neurogenesis in aging and age-related neurodegenerative diseases.Ageing Res Rev. 2022 Jun;78:101636. doi: 10.1016/j.arr.2022.101636. Epub 2022 Apr 29. Ageing Res Rev. 2022. PMID: 35490966 Free PMC article. Review.
-
Unlike dietary restriction, rapamycin fails to extend lifespan and reduce transcription stress in progeroid DNA repair-deficient mice.Aging Cell. 2021 Feb;20(2):e13302. doi: 10.1111/acel.13302. Epub 2021 Jan 23. Aging Cell. 2021. PMID: 33484480 Free PMC article.
-
Protein restriction and branched-chain amino acid restriction promote geroprotective shifts in metabolism.Aging Cell. 2022 Jun;21(6):e13626. doi: 10.1111/acel.13626. Epub 2022 May 8. Aging Cell. 2022. PMID: 35526271 Free PMC article. Review.
-
Distinct and additive effects of calorie restriction and rapamycin in aging skeletal muscle.Nat Commun. 2022 Apr 19;13(1):2025. doi: 10.1038/s41467-022-29714-6. Nat Commun. 2022. PMID: 35440545 Free PMC article.
References
-
- Sharp ZD, Bartke A. Evidence for down-regulation of phosphoinositide 3-kinase/Akt/mammalian target of rapamycin (PI3K/Akt/mTOR)-dependent translation regulatory signaling pathways in Ames dwarf mice. J Gerontol A Biol Sci Med Sci. 2005;60:293–300. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical